Cargando…

Oral Endothelium Corneum Gigeriae Galli Therapy for Pancreatic Duct Stones: A Prospective Cohort Study

BACKGROUND: Pancreatic duct stones obstruct the pancreatic ducts and aggravate clinical symptoms of chronic pancreatitis. Only isolated case reports have shown that some drugs may be useful in dissolving pancreatic duct stones. Endothelium corneum gigeriae galli is a Chinese medicine widely used to...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Dujuan, Li, Huiyu, Wang, Jinxi, Zhang, Fang, Zhao, Haoliang, Ren, Chongren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Turkish Society of Gastroenterology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797788/
https://www.ncbi.nlm.nih.gov/pubmed/36098361
http://dx.doi.org/10.5152/tjg.2022.22086
_version_ 1784860758728769536
author Cao, Dujuan
Li, Huiyu
Wang, Jinxi
Zhang, Fang
Zhao, Haoliang
Ren, Chongren
author_facet Cao, Dujuan
Li, Huiyu
Wang, Jinxi
Zhang, Fang
Zhao, Haoliang
Ren, Chongren
author_sort Cao, Dujuan
collection PubMed
description BACKGROUND: Pancreatic duct stones obstruct the pancreatic ducts and aggravate clinical symptoms of chronic pancreatitis. Only isolated case reports have shown that some drugs may be useful in dissolving pancreatic duct stones. Endothelium corneum gigeriae galli is a Chinese medicine widely used to cure multifarious lithiasis and maldigestion. This study aimed to evaluate the efficacy of endothelium corneum gigeriae galli oral therapy in the dissolution of stones and evaluate the improvement of clinical symptoms in patients with pancreatic duct stones. METHODS: Sixty-eight patients with pancreatic duct stones were randomly divided into the endothelium corneum gigeriae galli and control groups. Endothelium corneum gigeriae galli was given orally to the endothelium corneum gigeriae galli group, and the placebo was given to the control group. Both groups were reviewed by computed tomography and magnetic resonance imaging; abdominal pain, exocrine and endocrine pancreatic function, and the nutritional status of patients were measured after the study. RESULTS: The dissolution rate of the endothelium corneum gigeriae galli group was significantly higher than that of the control group (P = .002). The abdominal pain of the endothelium corneum gigeriae galli group was relieved more significantly compared to that of the control group (P < .001). The exocrine and endocrine pancreatic function of the endothelium corneum gigeriae galli group improved more significantly than that of the control group (P < .001). The nutritional status of the endothelium corneum gigeriae galli group was significantly higher than that of the control group (P = .003). CONCLUSION: Overall, oral endothelium corneum gigeriae galli treatment could dissolve pancreatic duct stones, relieve abdominal pain, improve exocrine and endocrine pancreatic functions, and control the deterioration of nutritional status. Endothelium corneum gigeriae galli treatment should be useful in pancreatic duct stones therapy.
format Online
Article
Text
id pubmed-9797788
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Turkish Society of Gastroenterology
record_format MEDLINE/PubMed
spelling pubmed-97977882023-01-04 Oral Endothelium Corneum Gigeriae Galli Therapy for Pancreatic Duct Stones: A Prospective Cohort Study Cao, Dujuan Li, Huiyu Wang, Jinxi Zhang, Fang Zhao, Haoliang Ren, Chongren Turk J Gastroenterol Original Article BACKGROUND: Pancreatic duct stones obstruct the pancreatic ducts and aggravate clinical symptoms of chronic pancreatitis. Only isolated case reports have shown that some drugs may be useful in dissolving pancreatic duct stones. Endothelium corneum gigeriae galli is a Chinese medicine widely used to cure multifarious lithiasis and maldigestion. This study aimed to evaluate the efficacy of endothelium corneum gigeriae galli oral therapy in the dissolution of stones and evaluate the improvement of clinical symptoms in patients with pancreatic duct stones. METHODS: Sixty-eight patients with pancreatic duct stones were randomly divided into the endothelium corneum gigeriae galli and control groups. Endothelium corneum gigeriae galli was given orally to the endothelium corneum gigeriae galli group, and the placebo was given to the control group. Both groups were reviewed by computed tomography and magnetic resonance imaging; abdominal pain, exocrine and endocrine pancreatic function, and the nutritional status of patients were measured after the study. RESULTS: The dissolution rate of the endothelium corneum gigeriae galli group was significantly higher than that of the control group (P = .002). The abdominal pain of the endothelium corneum gigeriae galli group was relieved more significantly compared to that of the control group (P < .001). The exocrine and endocrine pancreatic function of the endothelium corneum gigeriae galli group improved more significantly than that of the control group (P < .001). The nutritional status of the endothelium corneum gigeriae galli group was significantly higher than that of the control group (P = .003). CONCLUSION: Overall, oral endothelium corneum gigeriae galli treatment could dissolve pancreatic duct stones, relieve abdominal pain, improve exocrine and endocrine pancreatic functions, and control the deterioration of nutritional status. Endothelium corneum gigeriae galli treatment should be useful in pancreatic duct stones therapy. Turkish Society of Gastroenterology 2022-12-01 /pmc/articles/PMC9797788/ /pubmed/36098361 http://dx.doi.org/10.5152/tjg.2022.22086 Text en © Copyright 2022 authors https://creativecommons.org/licenses/by/4.0/ Content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. (https://creativecommons.org/licenses/by/4.0/)
spellingShingle Original Article
Cao, Dujuan
Li, Huiyu
Wang, Jinxi
Zhang, Fang
Zhao, Haoliang
Ren, Chongren
Oral Endothelium Corneum Gigeriae Galli Therapy for Pancreatic Duct Stones: A Prospective Cohort Study
title Oral Endothelium Corneum Gigeriae Galli Therapy for Pancreatic Duct Stones: A Prospective Cohort Study
title_full Oral Endothelium Corneum Gigeriae Galli Therapy for Pancreatic Duct Stones: A Prospective Cohort Study
title_fullStr Oral Endothelium Corneum Gigeriae Galli Therapy for Pancreatic Duct Stones: A Prospective Cohort Study
title_full_unstemmed Oral Endothelium Corneum Gigeriae Galli Therapy for Pancreatic Duct Stones: A Prospective Cohort Study
title_short Oral Endothelium Corneum Gigeriae Galli Therapy for Pancreatic Duct Stones: A Prospective Cohort Study
title_sort oral endothelium corneum gigeriae galli therapy for pancreatic duct stones: a prospective cohort study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797788/
https://www.ncbi.nlm.nih.gov/pubmed/36098361
http://dx.doi.org/10.5152/tjg.2022.22086
work_keys_str_mv AT caodujuan oralendotheliumcorneumgigeriaegallitherapyforpancreaticductstonesaprospectivecohortstudy
AT lihuiyu oralendotheliumcorneumgigeriaegallitherapyforpancreaticductstonesaprospectivecohortstudy
AT wangjinxi oralendotheliumcorneumgigeriaegallitherapyforpancreaticductstonesaprospectivecohortstudy
AT zhangfang oralendotheliumcorneumgigeriaegallitherapyforpancreaticductstonesaprospectivecohortstudy
AT zhaohaoliang oralendotheliumcorneumgigeriaegallitherapyforpancreaticductstonesaprospectivecohortstudy
AT renchongren oralendotheliumcorneumgigeriaegallitherapyforpancreaticductstonesaprospectivecohortstudy